The U.S. government will pay $1.95 billion to buy 100 million doses of Pfizer's and German biotech firm BioNTech's COVID-19 vaccine candidate if they are able to successfully develop one, the companies said on Wednesday.
Fred Katayama reports.
The U.S. government will pay $1.95 billion to buy 100 million doses of Pfizer's and German biotech firm BioNTech's COVID-19 vaccine candidate if they are able to successfully develop one, the companies said on Wednesday.
Fred Katayama reports.
Washington is to pay European drug giants Sanofi and GSK 2.1 billion dollars to cover vaccines for 50 million people. Julian..
German biotech firm BioNTech and U.S. drugmaker Pfizer Monday reported additional data from their experimental COVID-19 vaccine..